top of page
The Professional Network for Healthcare Experts
FDA approves Orzeyful as first treatment to address the full range of narcolepsy type 1 symptoms
The orexin receptor agonist provides adults with a treatment that targets the underlying loss of orexin signalling rather than managing individual symptoms separately.
nuaxia
Aug 72 min read
FDA approves Orzeyful as first treatment to address the full range of narcolepsy type 1 symptoms
The orexin receptor agonist provides adults with a treatment that targets the underlying loss of orexin signalling rather than managing individual symptoms separately.
nuaxia
Aug 62 min read
bottom of page